Dr. Lakdawala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Brigham And Women's Hospital - Cardiovascular Division
Boston, MA 02115Phone+1 857-307-4000Fax+1 617-264-5265
Education & Training
- Harvard School of Public HealthMSc, Epidemiology, 2007 - 2010
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2005 - 2008
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2001 - 2005
- The University of Texas Health Science Center at San AntonioClass of 2001
Certifications & Licensure
- MA State Medical License 2005 - 2025
- NH State Medical License 2024 - 2024
- ME State Medical License 2020 - 2021
- NY State Medical License 2003 - 2006
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) Start of enrollment: 2013 Apr 01
- Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2014 Apr 01
- Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure Start of enrollment: 2014 Dec 30
Publications & Presentations
PubMed
- FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy.Sanjay Divakaran, Vinay Randhawa, Usman A Tahir, Matthew Robertson, Anam A Waheed
ESC Heart Failure. 2025-04-01 - Long-term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights from VALOR-HCM Trial.Milind Y Desai, Anjali Owens, Sara Saberi, Andrew Wang, Kathy Wolski
Circulation. Genomic and Precision Medicine. 2025-03-31 - Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.Joshua K Meisner, Aaron Renberg, Eric D Smith, Yao-Chang Tsan, Brynn Elder
Circulation. 2025-03-18
Press Mentions
- Bristol Myers Squibb Shares Research Supporting Correlation Between New York Heart Association Functional Class (NYHA Class) and Mortality in Obstructive Hypertrophic CardiomyopathySeptember 10th, 2021
- Brigham and Women’s Hospital to Pilot Post-Discharge App with Heart PatientsApril 7th, 2015
- A Shocking Turn of EventsOctober 4th, 2018
Professional Memberships
- Member
- Heart Failure Society of AmericaMember
- International Society of Heart Lung TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: